US5156833A - Powder aerosol composition - Google Patents

Powder aerosol composition Download PDF

Info

Publication number
US5156833A
US5156833A US07/650,070 US65007091A US5156833A US 5156833 A US5156833 A US 5156833A US 65007091 A US65007091 A US 65007091A US 5156833 A US5156833 A US 5156833A
Authority
US
United States
Prior art keywords
powder
liquefied
composition
aerosol composition
nonionic surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US07/650,070
Inventor
Takao Osugi
Toshihiro Jinno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Assigned to LION CORPORATION, reassignment LION CORPORATION, ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: JINNO, TOSHIHIRO, OSUGA, TAKAO
Application granted granted Critical
Publication of US5156833A publication Critical patent/US5156833A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Definitions

  • This invention relates to a powder aerosol composition containing a powder homogeneously suspended in a liquefied petroleum gas or liquefied natural gas serving as a propellant.
  • Powder aerosol compositions are now utilized as an anti-perspirant, a body lotion, a foot spray, or the like cosmetic application.
  • These aerosol compositions generally contain a powder, such as talc, for improving feelings of usage, a powder anti-perspiration ingredient, such as aluminum chloride, and a propellant and are charged in valved containers. In use, the aerosol composition is dispensed through the valve as an aerosol.
  • an object of the present invention to provide a powder aerosol composition which is in the form of a homogeneous suspension and keeps the suspended state for a long period of time without forming aggregates of the powder.
  • Another object of the present invention is to provide a powder aerosol composition of the above-mentioned type which does not cause the clogging of valves of containers through which the composition is dispensed as an aerosol.
  • the present invention provides a powder aerosol composition which includes a powder, a liquefied propellant gas selected from the group consisting of liquefied petroleum gases and liquefied natural gases, and a nonionic surfactant which is substantially insoluble in the liquefied propellant gas.
  • the powder to be used in the present invention may be, for example, a material of powder and/or a powder antiperspirant.
  • Both organic and inorganic powder may be used as the material of powder.
  • suitable materials of powder are talc, kaolin, zinc oxide, titanium oxide, magnesium oxide, bentonite, silica, mica, zeolite, magnesium silicate, calcium silicate, petaloid silica, titanium mica, silk, nylon, polyethylene, polystyrene, polymethylmethacrylate and crosslinked polyacrylic acid. These substances may be used by themselves or as a mixture of two or more.
  • the material of powder generally has an average partcle size of 1-50 ⁇ m, preferably 3-30 ⁇ m and is generally used in an amount of 0.1-10% by weight, preferably 0.5-5% by weight based on the total weight of the composition.
  • the material of powder be formed from secondary particles each of which is an aggregate of primary particles, for reasons of attaining non-stickiness on the skin and of improving dry feeling on the skin.
  • Such a material of powder having a secondary structure is disclosed in detail in Japanese Published Unexamined Patent Application (Tokkyo Kokai) No. 63-130535 and may be obtained by aggregating primary particles having an average particle size of 0.1-10 ⁇ m. Secondary particles having a surface area of 50-200 m 2 /g, preferably 80-180 m 2 /g, a pore volume of 0.01-10 ml/g, preferably 0.05-5 ml/g, and an average particle size of 1-50 ⁇ m, preferably 3-30 ⁇ m and formed of silicic acid anhydride (silicon dioxide) or titanium oxide are preferably used. By using a material of powder with such a secondary structure, non-stickiness and dry feeling on the skin may be advantageously obtained.
  • the space defined between the primary particles serves as a passage through which sweat on the skin surface may be removed by evaporation.
  • the use of a material of powder with a secondary structure is also advantageous because the skin applied therewith is not whitened. This is probably attributed to relatively high light permeability of the secondary particles.
  • the powder anti-perspirant may be, for example, astringent single salts such as aluminum chloride, aluminum oxychloride, basic aluminum bromide, aluminum sulfate, aluminum chlorohydrate, aluminum zirconium chlorohydrate, zinc sulfate, aluminum phenolsulfonate, phenolsulfonate and basic aluminum zinc lactate, and complexes of these single salts with glycol, amino acid or the like complex-forming compounds. These substances may be used by themselves or as a mixture of two or more.
  • the anti-perspirant generally has an average particle size of 1-50 ⁇ m, preferably 3-30 ⁇ m, and is generally used in an amount of 0.2-10%, preferably 0.5-5% based on the total weight of the composition.
  • the liquefied propellant to be used in the present invention is a liquefied petroleum gas or a liquefied natural gas.
  • the liquefied petroleum gas and natural gas may be used in conjunction with one or more other propellants such as liquefied butane or the like liquefied hydrocarbons, if desired.
  • the liquefied propellant is generally used in an amount of 80-98%, preferably 85-96%, based on the total weight of the composition.
  • the nonionic surfactant to be used in the present invention is a liquid which is substantially insoluble in the above-described liquefied propellant.
  • Nonionic surfactants having a solubility of 1.0 g or less at 25 ° C., preferably 0.5 g or less at 25 ° C., in 100 g of the liquefied propellant may be suitably used.
  • nonionic surfactants examples include (1) polyesters of long chain fatty acids with glycerin having one or more oxyalkylene groups, such as polyoxyethylene glyceryl triisostearate (2) polyesters of long chain fatty acids with hardened castor oil, such as polyoxyethylene triisostearic acid ester of hardened castor oil (3) fatty acid esters of sorbitol having one or more oxyalkylene groups and (4) mixtures thereof.
  • the nonionic surfactant is generally used in an amount of 0.1-10% preferably 0.5-5% based on the total weight of the composition.
  • the nonionic surfactant is adsorbed or absorbed on the surfaces of the powder to improve the suspensibility of the powder in the liquefied propellant gas.
  • the aerosol composition according to the present invention may further contain one or more additives such as oils, germicides, inclusion compounds (e.g. cyclodextrin), vitamins, amino acids, anti-inflammatory agents (e.g. glycyrrhizinic acid), cooling agents (e.g. menthol), natural drugs and perfumes.
  • additives such as oils, germicides, inclusion compounds (e.g. cyclodextrin), vitamins, amino acids, anti-inflammatory agents (e.g. glycyrrhizinic acid), cooling agents (e.g. menthol), natural drugs and perfumes.
  • oils are fluid paraffin, isopropyl myristate, octyl myristate, dodecyl myristate, isopropyl palmitate, diisopropyl adipate, diisobutyl adipate, silicone oil, avocado oil, hohoba oil, lanoline, cetyl 2-ethylhexanoate, butyl isostearate, triethyl citrate, acetyltributyl citrate, butyl phthalate and cetyl octanoate.
  • suitable germicides are benzalkonium chloride, isopropylmethylphenol, triclosan, trichlorocarbanilide, chlorohexidine hydrochloride and benzethonium chloride.
  • Powder aerosol compositions (Nos. 1-11) were prepared using a liquefied peteroleum gas as a propellant, 0.1% by weight of a perfume, and anti-perspirants, materials of powder, oils and nonionic surfactants as shown in Table below in amounts shown in Table below. Each of the compositions was tested for its suspensibility and valve-clogging tendency. The results are summarized in Table below.
  • test methods are as follows:
  • the sample aerosol composition is charged in a transparent glass container and is shaked. Then, the container is allowed to quiescently stand for a predetermined period of time. Suspensibility is evaluated based on the following ratings:
  • the sample aerosol composition is charged in a valved container, shaked and allowed to stand at 40 ° C., for 3 months.
  • the composition is sprayed once a week to check whether or not the valve is clogged. Clogging tendency is evaluated based on the following ratings:
  • IPM Isopropyl myristate
  • PGT Polyoxyethyleneglyceryl triisostearate (ethylene oxide addition mol number: 20)
  • PCT Polyoxyethylene hardened castor oil triisostearate (ethylene oxide addition mol number: 20)
  • PNE Polyoxyethylene nonylphenyl ether (ethylene oxide addition mol number: 2)
  • the silica used in this example is spherical silica micro bead (manufactured by SHOKUBAI KASEI K. K.) having a secondary structure.
  • Compositions Nos. 1-8 are those of the present invention while Compositions Nos. 9-11 are comparative ones.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

A powder aerosol composition is disclosed which includes a powder, a liquefied propellant gas selected from liquefied petroleum gases and liquefied natural gases, and a nonionic surfactant which is substantially insoluble in the liquefied propellant gas.

Description

BACKGROUND OF THE INVENTION
This invention relates to a powder aerosol composition containing a powder homogeneously suspended in a liquefied petroleum gas or liquefied natural gas serving as a propellant.
Powder aerosol compositions are now utilized as an anti-perspirant, a body lotion, a foot spray, or the like cosmetic application. These aerosol compositions generally contain a powder, such as talc, for improving feelings of usage, a powder anti-perspiration ingredient, such as aluminum chloride, and a propellant and are charged in valved containers. In use, the aerosol composition is dispensed through the valve as an aerosol.
While fluorocarbons have been used as the propellant, recent trend is toward the use of a liquefied petroleum gas or a liquefied natural gas for reasons of environmental pollution caused by fluorocarbons. The use of a liquefied petroleum or natural gas propellant, however, has been found to pose a problem because the powder tends to aggregate in the liquefied propellant so that the valves are clogged during use.
SUMMARY OF THE INVENTION
It is, therefore, an object of the present invention to provide a powder aerosol composition which is in the form of a homogeneous suspension and keeps the suspended state for a long period of time without forming aggregates of the powder.
Another object of the present invention is to provide a powder aerosol composition of the above-mentioned type which does not cause the clogging of valves of containers through which the composition is dispensed as an aerosol.
In accomplishing the foregoing objects, the present invention provides a powder aerosol composition which includes a powder, a liquefied propellant gas selected from the group consisting of liquefied petroleum gases and liquefied natural gases, and a nonionic surfactant which is substantially insoluble in the liquefied propellant gas.
Other objects, features and advantages of the present invention will become apparent from the detailed description of the preferred embodiments of the invention to follow.
DESCRIPTION OF PREFERRED EMBODIMENTS
The powder to be used in the present invention may be, for example, a material of powder and/or a powder antiperspirant.
Both organic and inorganic powder may be used as the material of powder. Illustrative of suitable materials of powder are talc, kaolin, zinc oxide, titanium oxide, magnesium oxide, bentonite, silica, mica, zeolite, magnesium silicate, calcium silicate, petaloid silica, titanium mica, silk, nylon, polyethylene, polystyrene, polymethylmethacrylate and crosslinked polyacrylic acid. These substances may be used by themselves or as a mixture of two or more. The material of powder generally has an average partcle size of 1-50 μm, preferably 3-30 μm and is generally used in an amount of 0.1-10% by weight, preferably 0.5-5% by weight based on the total weight of the composition.
It is preferred that the material of powder be formed from secondary particles each of which is an aggregate of primary particles, for reasons of attaining non-stickiness on the skin and of improving dry feeling on the skin.
Such a material of powder having a secondary structure is disclosed in detail in Japanese Published Unexamined Patent Application (Tokkyo Kokai) No. 63-130535 and may be obtained by aggregating primary particles having an average particle size of 0.1-10 μm. Secondary particles having a surface area of 50-200 m2 /g, preferably 80-180 m2 /g, a pore volume of 0.01-10 ml/g, preferably 0.05-5 ml/g, and an average particle size of 1-50 μm, preferably 3-30 μm and formed of silicic acid anhydride (silicon dioxide) or titanium oxide are preferably used. By using a material of powder with such a secondary structure, non-stickiness and dry feeling on the skin may be advantageously obtained. This is considered to result from the porous structure of the secondary particles formed between the primary particles. The space defined between the primary particles serves as a passage through which sweat on the skin surface may be removed by evaporation. The use of a material of powder with a secondary structure is also advantageous because the skin applied therewith is not whitened. This is probably attributed to relatively high light permeability of the secondary particles.
The powder anti-perspirant may be, for example, astringent single salts such as aluminum chloride, aluminum oxychloride, basic aluminum bromide, aluminum sulfate, aluminum chlorohydrate, aluminum zirconium chlorohydrate, zinc sulfate, aluminum phenolsulfonate, phenolsulfonate and basic aluminum zinc lactate, and complexes of these single salts with glycol, amino acid or the like complex-forming compounds. These substances may be used by themselves or as a mixture of two or more. The anti-perspirant generally has an average particle size of 1-50 μm, preferably 3-30 μm, and is generally used in an amount of 0.2-10%, preferably 0.5-5% based on the total weight of the composition.
The liquefied propellant to be used in the present invention is a liquefied petroleum gas or a liquefied natural gas. The liquefied petroleum gas and natural gas may be used in conjunction with one or more other propellants such as liquefied butane or the like liquefied hydrocarbons, if desired. The liquefied propellant is generally used in an amount of 80-98%, preferably 85-96%, based on the total weight of the composition.
The nonionic surfactant to be used in the present invention is a liquid which is substantially insoluble in the above-described liquefied propellant. Nonionic surfactants having a solubility of 1.0 g or less at 25 ° C., preferably 0.5 g or less at 25 ° C., in 100 g of the liquefied propellant may be suitably used. Examples of the nonionic surfactants include (1) polyesters of long chain fatty acids with glycerin having one or more oxyalkylene groups, such as polyoxyethylene glyceryl triisostearate (2) polyesters of long chain fatty acids with hardened castor oil, such as polyoxyethylene triisostearic acid ester of hardened castor oil (3) fatty acid esters of sorbitol having one or more oxyalkylene groups and (4) mixtures thereof. The nonionic surfactant is generally used in an amount of 0.1-10% preferably 0.5-5% based on the total weight of the composition. When the powder is mixed with the liquefied propellant gas, the nonionic surfactant is adsorbed or absorbed on the surfaces of the powder to improve the suspensibility of the powder in the liquefied propellant gas.
The aerosol composition according to the present invention may further contain one or more additives such as oils, germicides, inclusion compounds (e.g. cyclodextrin), vitamins, amino acids, anti-inflammatory agents (e.g. glycyrrhizinic acid), cooling agents (e.g. menthol), natural drugs and perfumes. Illustrative of suitable oils are fluid paraffin, isopropyl myristate, octyl myristate, dodecyl myristate, isopropyl palmitate, diisopropyl adipate, diisobutyl adipate, silicone oil, avocado oil, hohoba oil, lanoline, cetyl 2-ethylhexanoate, butyl isostearate, triethyl citrate, acetyltributyl citrate, butyl phthalate and cetyl octanoate. Illustrative of suitable germicides are benzalkonium chloride, isopropylmethylphenol, triclosan, trichlorocarbanilide, chlorohexidine hydrochloride and benzethonium chloride.
The following examples will further illustrate the present invention.
EXAMPLE
Powder aerosol compositions (Nos. 1-11) were prepared using a liquefied peteroleum gas as a propellant, 0.1% by weight of a perfume, and anti-perspirants, materials of powder, oils and nonionic surfactants as shown in Table below in amounts shown in Table below. Each of the compositions was tested for its suspensibility and valve-clogging tendency. The results are summarized in Table below.
The test methods are as follows:
Suspensibility Test
The sample aerosol composition is charged in a transparent glass container and is shaked. Then, the container is allowed to quiescently stand for a predetermined period of time. Suspensibility is evaluated based on the following ratings:
A: Good suspensibility
B: No good suspensibility
C: Poor suspensibility
Clogging Test
The sample aerosol composition is charged in a valved container, shaked and allowed to stand at 40 ° C., for 3 months. The composition is sprayed once a week to check whether or not the valve is clogged. Clogging tendency is evaluated based on the following ratings:
A: No clogging for 3 months.
B: Valve is clogged within 3 months.
In Table, the abbreviations are as follows:
ACH: Aluminum chlorohydrate
IPM: Isopropyl myristate
IPP: Isopropyl palmitate
CMP: Cyclic methylpolysiloxane
PGT: Polyoxyethyleneglyceryl triisostearate (ethylene oxide addition mol number: 20)
PCT: Polyoxyethylene hardened castor oil triisostearate (ethylene oxide addition mol number: 20)
PNE: Polyoxyethylene nonylphenyl ether (ethylene oxide addition mol number: 2)
The silica used in this example is spherical silica micro bead (manufactured by SHOKUBAI KASEI K. K.) having a secondary structure. Compositions Nos. 1-8 are those of the present invention while Compositions Nos. 9-11 are comparative ones.
______________________________________                                    
Composition                                                               
No.        1     2     3   4   5   6   7   8   9   10  11                 
______________________________________                                    
Anti-perspirant                                                           
ACH        2.0   2.0   2.0 2.0 2.0 2.0 --  --  2.0 2.0 2.0                
Aluminum chloride                                                         
           --    --    --  --  --  --  2.0 2.0 --  --  --                 
Powder Substrate                                                          
Talc       2.5   --    --  2.5 2.5 2.5 --  --  2.5 2.5 2.5                
Silica     --    2.5   --  --  --  --  2.5 1.5 --  --  --                 
Kaolin     --    --    2.5 --  --  --  --  1.0 --  --  --                 
Oil                                                                       
IPM        3.0   3.0   3.0 3.0 3.0 --  --  3.0 3.0 3.0 3.0                
IPP        --    --    --  --  --  3.0 --  --  --  --  --                 
CMP        --    --    --  --  --  --  3.0 --  --  --  --                 
Surfactant                                                                
PGT        2.0   2.0   2.0 4.0 --  2.0 2.0 1.0 --  --  --                 
PCT        --    --    --  --  2.0 --  --  1.0 --  --  --                 
PNE        --    --    --  --  --  --  --  --  --  2.0 5.0                
Suspensibility                                                            
           A     A     A   A   A   A   A   A   C   B   B                  
Clogging   A     A     A   A   A   A   A   A   C   C   C                  
Tendency                                                                  
______________________________________
As will be evident from the results shown in Table above, the use of nonionic surfactants (PGT and PCT) which are insoluble in liquefied petroleum gas provides powder aerosol compositions having good suspensibility and free of valve-clogging. A nonionic surfactant (PNE) which is soluble in liquefied petroleum gas, on the other hand, fails to achieve the objects of the present invention.
The invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all the changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.

Claims (4)

What is claimed is:
1. A powder aerosol composition comprising:
a powder;
a liquefied propellant gas selected from the group consisting of liquefied petroleum gases and liquefied natural gases; and
a nonionic surfactant which is polyoxyethyleneglyceryl triisostearate or polyoxyethylene hardened castor oil triisostearate, said surfactant being substantially insoluble in said liquefied propellant gas.
2. A composition as claimed in claim 1, wherein said powder is present in said composition in an amount of 0.1-20% by weight.
3. A composition as claimed in claim 1, wherein the content of said nonionic surfactant is in the range of 0.1-10% by weight.
4. A composition as claimed in claim 1, wherein said powder has an average particle size of 1-50 μm.
US07/650,070 1990-02-07 1991-02-04 Powder aerosol composition Expired - Fee Related US5156833A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2-26202 1990-02-07
JP2620290 1990-02-07

Publications (1)

Publication Number Publication Date
US5156833A true US5156833A (en) 1992-10-20

Family

ID=12186886

Family Applications (1)

Application Number Title Priority Date Filing Date
US07/650,070 Expired - Fee Related US5156833A (en) 1990-02-07 1991-02-04 Powder aerosol composition

Country Status (1)

Country Link
US (1) US5156833A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0633019A1 (en) 1993-07-08 1995-01-11 ASTA Medica Aktiengesellschaft Pressurized gas packagings using polyoxyethylene glyceryl fatty acid esters as suspension stabilizers and valve lubricants
EP0792632A1 (en) * 1996-03-01 1997-09-03 L'oreal Pressurized transparent apparatus with a foaming composition containing non ionic and amphoteric surfactants
US5725836A (en) * 1993-11-08 1998-03-10 Cf Technologies, Inc. Method of forming particles using a supercritical fluid, aerogel particles formed thereby, and antiperspirants containing aerogel particles
US5800805A (en) * 1997-06-19 1998-09-01 Church & Dwight Co., Inc Aerosol deodorant product
US5945085A (en) * 1997-06-19 1999-08-31 Church & Dwight Co., Inc. Aerosol deodorant-antiperspirant product
FR2831164A1 (en) * 2001-10-19 2003-04-25 Toms Ledins Lachrymogenic CS (o-chlorobenzylidene malononitrile) powder useful for riot control or in defense applications
FR2838348A1 (en) * 2002-12-20 2003-10-17 Oreal Use of alkoxylated polyol fatty acid esters in cosmetic compositions as agents for inhibiting adhesion of microorganisms to the surface of the skin and/or mucosa
RU2245789C2 (en) * 1999-11-12 2005-02-10 Каргласс Люксембург С.А.Р.Л.-Цуг Бранч Upgraded device and a method for correction of faults
US20060205616A1 (en) * 2005-03-09 2006-09-14 Alberto-Culver Company Sustained-release fragrance delivery system
US8778406B2 (en) 2010-08-10 2014-07-15 Joyce Labs, Llc Anti-chafing aerosol powder

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183911A (en) * 1973-09-18 1980-01-15 Colgate-Palmolive Company Antiperspirant compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183911A (en) * 1973-09-18 1980-01-15 Colgate-Palmolive Company Antiperspirant compositions

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0633019A1 (en) 1993-07-08 1995-01-11 ASTA Medica Aktiengesellschaft Pressurized gas packagings using polyoxyethylene glyceryl fatty acid esters as suspension stabilizers and valve lubricants
US5725836A (en) * 1993-11-08 1998-03-10 Cf Technologies, Inc. Method of forming particles using a supercritical fluid, aerogel particles formed thereby, and antiperspirants containing aerogel particles
US5864923A (en) * 1993-11-08 1999-02-02 Cf Technologies, Inc. Method of forming particles using a supercritical fluid
EP0792632A1 (en) * 1996-03-01 1997-09-03 L'oreal Pressurized transparent apparatus with a foaming composition containing non ionic and amphoteric surfactants
WO1997031615A1 (en) * 1996-03-01 1997-09-04 L'oreal Pressurised transparent device for a foaming composition including non-ionic and amphoteric surfactants
FR2745496A1 (en) * 1996-03-01 1997-09-05 Oreal TRANSPARENT PRESSURIZED DEVICE WITH FOAMING COMPOSITION COMPRISING NON-IONIC AND AMPHOTERIC SURFACTANTS
US5888478A (en) * 1996-03-01 1999-03-30 L'oreal Transparent pressurized device with foaming composition including nonionic and amphoteric surfactants
CN1082802C (en) * 1996-03-01 2002-04-17 莱雅公司 Transparent booster device for foaming compositions containing nonionic and amphoteric surfactants
US5800805A (en) * 1997-06-19 1998-09-01 Church & Dwight Co., Inc Aerosol deodorant product
US5945085A (en) * 1997-06-19 1999-08-31 Church & Dwight Co., Inc. Aerosol deodorant-antiperspirant product
RU2245789C2 (en) * 1999-11-12 2005-02-10 Каргласс Люксембург С.А.Р.Л.-Цуг Бранч Upgraded device and a method for correction of faults
FR2831164A1 (en) * 2001-10-19 2003-04-25 Toms Ledins Lachrymogenic CS (o-chlorobenzylidene malononitrile) powder useful for riot control or in defense applications
FR2838348A1 (en) * 2002-12-20 2003-10-17 Oreal Use of alkoxylated polyol fatty acid esters in cosmetic compositions as agents for inhibiting adhesion of microorganisms to the surface of the skin and/or mucosa
US20060205616A1 (en) * 2005-03-09 2006-09-14 Alberto-Culver Company Sustained-release fragrance delivery system
WO2006098878A1 (en) * 2005-03-09 2006-09-21 Alberto-Culver Company Sustained-release fragrance delivery system
GB2438144A (en) * 2005-03-09 2007-11-14 Alberto Culver Co Sustained-release fragrance delivery system
GB2438144B (en) * 2005-03-09 2009-07-15 Alberto Culver Co Sustained-release fragrance delivery system
US7638477B2 (en) 2005-03-09 2009-12-29 Alberto-Culver Company Sustained-release fragrance delivery system
AU2006223570B2 (en) * 2005-03-09 2010-12-16 Wellspring Pharmaceutical Corporation Sustained-release fragrance delivery system
US8778406B2 (en) 2010-08-10 2014-07-15 Joyce Labs, Llc Anti-chafing aerosol powder

Similar Documents

Publication Publication Date Title
CA1142437A (en) Zinc carbonate in deodorant compositions
US5223244A (en) Aerosol composition
US4605554A (en) Roll-on application of aqueous microencapsulated products
JPH057062B2 (en)
US5156833A (en) Powder aerosol composition
MXPA05006068A (en) High efficacy, low irritation aluminum salts and antiperspirant products.
GB2191945A (en) Powders for make-up or body or face care
US5961995A (en) Cosmetic composition
ZA200603027B (en) Compositions comprising odor neutralizing metal oxide silicates
US3773683A (en) Novel suspending agent composition for use in powder aerosol compositions and process for preparation
GB2113706A (en) Aersol antiperspirant composition
US7718184B2 (en) Hydrophobically coated/treated metal silicate absorbent particles and personal care compositions thereof
EP0792634A2 (en) Antiperspirant aerosol composition and method of making same
PL199350B1 (en) Particulate ANTIPERSPIRANT MATERIAL, method of its surface treatment AND COMPOSITIONS CONTAINING IT
RU2391963C2 (en) Antiperspirant aerosol product with treated against corrosion container
AU2003249933B2 (en) Antiperspirant aerosol compositions
MXPA04012873A (en) Antiperspirant emulsion compositions.
JP2706693B2 (en) Aerosol composition
EP1021157B1 (en) Alcoholic antiperspirant aerosol spray products
JP3785664B2 (en) Antiperspirant spray composition
EP0348091B1 (en) Aerosol composition
WO1996018378A2 (en) Single phase aerosol antiperspirant composition
CA1324577C (en) Cosmetic product
JP2873833B2 (en) Powder aerosol cosmetics
JP2004231591A (en) Powder-containing cosmetics

Legal Events

Date Code Title Description
AS Assignment

Owner name: LION CORPORATION,, JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:OSUGA, TAKAO;JINNO, TOSHIHIRO;REEL/FRAME:005595/0883

Effective date: 19910122

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Lapsed due to failure to pay maintenance fee

Effective date: 20001020

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362